SEC Form 4 · accession 0001093557-15-000074
DEXCOM INC · DXCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin R Sayer
Officer — President & CEO · Director
Period of report
Mar 11, 2015
Accepted (ET)
Mar 13, 2015 · 7:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001093557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Mar 11, 2015 | D | 8,680 | $58.7402 | D | 472,172 | D | |
| Common StockF1,F2 | Mar 11, 2015 | D | 26,469 | $58.7402 | D | 445,703 | D | |
| Common StockF1,F2 | Mar 12, 2015 | D | 13,343 | $58.5769 | D | 432,360 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted.
- F2Included in this number are 240,000 unvested restricted stock units, 90,000 of which were granted on March 8, 2015 and shall vest through March 8, 2018, 100,000 of which were granted on March 8, 2014 and shall vest through March 8, 2017, and 50,000 of which were granted on March 11, 2013 and shall vest through March 11, 2016.